#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4350	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2016	405.8	0	.	n	.	0	C114T	SNP	114	114	C	475	475	T	419	T,C	217,49	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4350	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2016	405.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1545	1545	C	551	C,A,G	342,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4350	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2016	405.8	0	HET	.	.	.	C1450T	.	1450	1450	C	1811	1811	C	485	C,T	76,231	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7844	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3529	418.5	0	.	n	.	0	T695C	SNP	695	695	T	911	911	C	556	C	336	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7844	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3529	418.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1553	1553	A	446	A	286	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7844	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3529	418.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2187	2187	C	407	C	260	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7844	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3529	418.5	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2813	2813	T	400	T	247	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7844	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3529	418.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2261	2261	A	428	A	272	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	276	folP	855	855	100.0	folP.l15.c4.ctg.1	1569	33.1	1	SNP	p	R229S	1	.	.	685	687	AGC	1148	1150	AGC	45;45;44	A;G;C	28;28;28	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	738	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3266	42.1	0	.	p	.	0	D95A	NONSYN	283	285	GAC	599	601	GCC	58;58;58	G;C;C	36;37;37	.	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	738	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3266	42.1	1	SNP	p	S91F	1	.	.	271	273	TTC	587	589	TTC	54;54;54	T;T;C	34;34;34	gyrA.WHO_G_01105:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	216	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1171	35.2	1	SNP	p	G45D	0	.	.	133	135	GGC	329	331	GGC	57;57;57	G;G;C	34;35;34	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	142	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	726	34.2	0	.	n	.	0	A197.	DEL	197	197	A	391	391	A	55	A	36	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	704	parC	2304	2304	99.91	parC.l15.c17.ctg.1	2927	44.4	1	SNP	p	D86N	0	.	.	256	258	GAC	456	458	GAC	44;44;45	G;A;C	27;23;27	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	704	parC	2304	2304	99.91	parC.l15.c17.ctg.1	2927	44.4	1	SNP	p	R87W	0	.	.	259	261	CGT	459	461	CGT	45;46;46	C;G;T	28;28;28	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	704	parC	2304	2304	99.91	parC.l15.c17.ctg.1	2927	44.4	1	SNP	p	S87R	1	.	.	259	261	CGT	459	461	CGT	45;46;46	C;G;T	28;28;28	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	704	parC	2304	2304	99.91	parC.l15.c17.ctg.1	2927	44.4	1	SNP	p	R87I	0	.	.	259	261	CGT	459	461	CGT	45;46;46	C;G;T	28;28;28	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	704	parC	2304	2304	99.91	parC.l15.c17.ctg.1	2927	44.4	1	SNP	p	S88P	0	.	.	262	264	TCC	462	464	TCC	46;47;45	T,G;C;C	27,1;28;28	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	576	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2418	44.6	0	.	p	.	0	P456S	NONSYN	1366	1368	CCC	1577	1579	TCC	41;41;41	T;C;C	23;26;27	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	576	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2418	44.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1439	1441	GGC	40;40;40	G;G;C,G	27;23;23,2	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	716	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2200	56.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1224	1226	GCA	68;68;69	G;C;A	45;44;44	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	716	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2200	56.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1227	1229	ATC	71;71;71	A;T;C	44;47;46	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	716	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2200	56.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1239	1241	GTG	72;70;70	G;T;G	46;45;44	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	716	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2200	56.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1239	1241	GTG	72;70;70	G;T;G	46;45;44	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	716	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2200	56.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1743	1745	ACC	43;43;41	A;C;C	27;30;28	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	716	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2200	56.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1797	1799	GCG	29;31;32	G;C;G	21;20;20	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	716	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2200	56.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1797	1799	GCG	29;31;32	G;C;G	21;20;20	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	716	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2200	56.3	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1920	1922	AGC	47;47;47	A;G;C	31;30;27	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	716	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2200	56.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1929	1931	GGC	45;45;44	G;G;C	30;31;27	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	716	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2200	56.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1947	1949	CCG	43;43;43	C;C;G	27;28;25	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1298	ponA	2397	2397	100.0	ponA.l15.c17.ctg.1	2778	80.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1435	1437	CCG	40;40;40	C;C;G	24;26;28	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	352	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1912	35.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	518	518	C	22	C	13	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	504	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1409	66.1	0	.	p	.	0	N38E	NONSYN	112	114	AAT	389	391	GAA	93;91;91	G;A;A	64;60;61	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	504	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1409	66.1	0	.	p	.	0	N134D	NONSYN	400	402	AAT	677	679	GAT	72;73;73	G;A;T	46;45;48	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	504	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1409	66.1	0	.	p	.	0	G140R	NONSYN	418	420	GGA	695	697	AGA	75;75;74	A;G;A	48;46;48	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	504	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1409	66.1	0	.	p	.	0	P175S	NONSYN	523	525	CCA	800	802	TCA	79;78;78	T,C;C;A	48,1;48;49	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	504	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1409	66.1	0	.	p	.	0	A218I	NONSYN	652	654	GCC	929	931	ATC	88;95;96	A;T;C	54;55;58	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	504	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1409	66.1	1	SNP	p	G120K	1	.	.	358	360	AAG	635	637	AAG	61;62;62	A;A;G	39;39;41	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	504	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1409	66.1	1	SNP	p	D121N	0	.	.	361	363	GAC	638	640	GAC	64;64;64	G;A;C	41;39;43	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	504	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1409	66.1	1	SNP	p	A121D	1	.	.	361	363	GAC	638	640	GAC	64;64;64	G;A;C	41;39;43	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2014	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4888	78.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	232	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	943	47.9	1	SNP	p	V57M	1	.	.	169	171	ATG	455	457	ATG	92;87;89	A;T;G	60;56;58	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
